Technology | Hybrid OR | March 03, 2017

System offers intuitive user interface combined with real-time information on multiple work spots within the interventional lab

Philips, Azurion platform, angiography, interventional lab, global launch

March 3, 2017 — Philips recently announced the global launch of Azurion, its next-generation image-guided therapy platform.

The Azurion image-guided therapy platform for interventional labs is the result of a multi-year development program conducted in close collaboration with leading clinicians in the field. The company said this next generation platform features a state-of-the-art ergonomic design with an easy-to-use intuitive user interface, enabling clinicians to swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.

With the rapid growth of image-guided therapy procedures, hospitals and health systems are increasingly faced with the need to control costs, while improving their standards of care. Philips said Azurion has been designed to address these challenges and is equipped with new workflow options and performance dashboards, as well as an upcoming range of productivity improvement services.

The Azurion platform also features over 1,000 new components, including an enhanced flat-panel detector, and Philips’ newly developed ConnectOS operating system for the seamless integration of real-time information from all relevant technologies in the interventional lab. All of these components work together to deliver high image quality at ultra-low X-ray dose and real-time image processing on multiple work spots within the interventional lab. Parallel working enables the team of clinicians to complete different tasks simultaneously in the interventional lab, saving valuable time without compromising quality of care. Azurion features procedure cards that allow clinicians to pre-program routine tasks and user preferences, helping to minimize preparation errors and further reducing preparation and procedure time.

Other Philips advanced interventional tools are integrated into the Azurion platform, including:

  • VesselNavigator for vascular surgery;
  • EchoNavigator for interventional cardiology;
  • EmboGuide for inteventional oncology; and
  • AneurysmFlow for interventional neuroradiology.

Driven by their benefits for patients and care providers, minimally-invasive therapies, such as the catheter-based treatment of certain tumors, aneurysms, obstructed blood vessels, heart rhythm disorders and defective heart valves, continue to grow fast. In addition to reduced patient trauma and shorter recovery times, such procedures also have the benefit of allowing the treatment of patients who would not be able to withstand the trauma of open surgery. However, during such procedures, clinicians cannot directly see and feel the organs they are working on. Effective imaging, measurement and navigation technologies are therefore key to guiding minimally-invasive procedures. At the heart of the interventional lab, these technologies allow identification and visualization of target organs and tissues, the operation of interventional devices, and the placement of implants, leading to improved chances of therapy success.

“For over 30 years, we’ve pioneered minimally-invasive treatments that help our patients get back to their daily lives,” said Barry T. Katzen, M.D., founder and chief medical executive of the Miami Cardiac & Vascular Institute, Baptist Health South Florida. “The imaging environment is critical to perform such procedures efficiently and effectively. As an interventionalist, we want to be in the cockpit, similar to a pilot in an airplane, where we have control of everything we need and have all the relevant functions at our fingertips. Philips’ next-generation image-guided therapy platform just takes it to a whole other level and allows interventionalists to accomplish the procedures quicker and more efficiently, which benefits the patient."

For more information: www.usa.phililps.com/healthcare

Related Content

Feature | Mobile C-Arms | By Bhvita Jani

With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources ...

Time July 07, 2021
arrow
News | Angiography

December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...

Time December 01, 2020
arrow
News | Mobile C-Arms

August 18, 2020 — Ziehm Imaging announces the acquisition of Therenva, a French-based developer of planning and imaging ...

Time August 18, 2020
arrow
News | Computed Tomography (CT)

February 10, 2020 — The U.S. Food and Drug Administration (FDA) has cleared patient-specific airway stents developed by ...

Time February 10, 2020
arrow
Feature | RSNA | Dave Fornell, Editor

Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the Radiological ...

Time January 20, 2020
arrow
Videos | Radiation Dose Management

Mahadevappa Mahesh, Ph.D., chief of medical physicist and professor of radiology and medical physics, Johns Hopkins ...

Time December 19, 2019
arrow
Technology | Interventional Radiology

October 28, 2019 — Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from ...

Time October 28, 2019
arrow
Technology | Mobile C-Arms

Advanced X-ray imaging systems developer Turner Imaging Systems announced the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Smart-C mini C-arm portable fluoroscopy and X-ray imaging device. Focused on mobility and portability, the patent-pending Smart-C weighs only 16 pounds so that it can be hand-carried to the point of care, with no need for special equipment to wheel the device around.

Time October 23, 2019
arrow
News | Angiography

In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most advanced systems while also keeping costs down. Providers now have a solution from Canon Medical Systems USA: the Alphenix Encore Plus Program. The program enables customers to upgrade their aging angiography systems to the latest technology while maintaining many existing parts, delivering clinical excellence, operational continuity and cost savings.

Time October 09, 2019
arrow
News | CT Angiography (CTA)

The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary syndromes (CCS), which classifies computed tomography angiography (CTA) as a Class 1 recommendation for diagnosing CAD in symptomatic patients. The document, which is a continuation of the 2013 stable coronary artery disease (CAD) guidelines, updates the term to CCS to emphasize the dynamic nature of the disease. It was released at the 2019 ESC Congress, Aug. 31-Sept. 4 in Paris, France, and published simultaneously in the European Heart Journal.

Time September 17, 2019
arrow
Subscribe Now